Switch to:
More From Other Websites
Want To Control Drug Prices? Reject Price Controls! Jan 26 2015
German insurers win discounts on Gilead's Sovaldi Jan 24 2015
German insurers win discounts on Gilead's Sovaldi Jan 24 2015
The Drug Price War Pitting Insurers Against Big Pharma Jan 22 2015
Express Scripts Targets $150,000 Cancer Drug Prices in 2016 Plan Jan 22 2015
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales Jan 21 2015
Regeneron CEO: Choice, not price best for patients Jan 20 2015
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog Jan 19 2015
5 Trade Ideas for Tuesday: Allstate, Anheuser-Busch InBev, Ashland, Express Scripts, Northrup... Jan 18 2015
Aetna picks Gilead Sciences hepatitis C drugs over AbbVie's Jan 16 2015
Aetna picks Gilead Sciences hepatitis C drugs over AbbVie's Jan 16 2015
CORRECTED (OFFICIAL)-UPDATE 1-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 2015
Express Scripts Announces Fourth Quarter 2014 Earnings Conference Call and Webcast of Investor Day... Jan 16 2015
Aetna Sides With Gilead In Hepatitis C Drug Battle Jan 16 2015
Gilead Strikes Another Deal Jan 16 2015
Express Scripts Holding Company (ESRX): New Analyst Report from Zacks Equity Research - Zacks Equity... Jan 16 2015
5 Breakout Trades for 2015 Gains: Apple, Goldman Sachs and More Jan 15 2015
Insight - Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015
Big Pharma faces up to new price pressure from aggressive insurers Jan 15 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Srichardson
ReplySrichardson - 5 months ago
How do you see the % of Total Asset for a position in a guru portfolio?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK